<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03542968</url>
  </required_header>
  <id_info>
    <org_study_id>2017-A01482-51</org_study_id>
    <nct_id>NCT03542968</nct_id>
  </id_info>
  <brief_title>Imaging by 4 DFlow in Patients With Tetralogy of Fallot</brief_title>
  <acronym>4DFlowFallot</acronym>
  <official_title>Imaging by 4 DFlow in Patients With Tetralogy of Fallot</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Chirurgical Marie Lannelongue</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Chirurgical Marie Lannelongue</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Conventionnal cadiac magnetic resonance (CMR) is the reference to assess changes in right&#xD;
      heart flow and pulmonary artery hemodynamics in patients with repaired Tetralogy of Fallot.&#xD;
&#xD;
      4D Flow CMR Imaging is a new imaging modality able to assess all of these parameters faster&#xD;
      (8 min vs 30 min) and more comfortably.&#xD;
&#xD;
      The aim of this study is to compare conventionnal CMR and 4D Flow CMR for the assessment of&#xD;
      these parameters (ventricular volume, ventricular systolic function, and regurgitation of the&#xD;
      pulmonary pathway).&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Congenital heart disease, or corrected heart disease requires regular, specialized follow-up&#xD;
      throughout the life of these patients. Among the recommended examinations, cardiac MRI is the&#xD;
      reference for functionnal ventricles assessment (volume/systolic function), particularly for&#xD;
      the right ventricle.&#xD;
&#xD;
      Among these pathologies, the tetralogy of Fallot is indicative of the increasing importance&#xD;
      of cardiac MRI. In this disease, strong parameters has been identifies for the follow to&#xD;
      prevent right ventricle dysfunction and ventricular arrhythmias. They rely on right ventricle&#xD;
      volumes and on the pulmonary artery regurgitation, both using cardiac MRI.&#xD;
&#xD;
      However, this imaging modality imposes constraints such as a long acquisition times (30 to 40&#xD;
      min) or the need to hold apneas, which may render the procedure uncomfortable, even more in&#xD;
      the case of very young patients.&#xD;
&#xD;
      The idea of exploring a new imaging modality is therefore based on the willingness to offer a&#xD;
      faster and more comfortable examination. 4D Flow MRI could enable conventionnal parameters,&#xD;
      detection of both normal and abnormal right heart flow patterns, and may allow comprehensive&#xD;
      analysis of post-surgically altered geometries and hemodynamics.&#xD;
&#xD;
      4D Flow MRI cardiac imaging is :&#xD;
&#xD;
        -  A single and faster acquisition (8 to 15 minutes) that cardiac MRI.&#xD;
&#xD;
        -  A free breathing acquisition Imaging modality.&#xD;
&#xD;
        -  A quite-isotropic assessment.&#xD;
&#xD;
        -  A technically simple exam (a single sequence requiring low competence).&#xD;
&#xD;
        -  And offers unlimited post processing.&#xD;
&#xD;
      The investigators hypothesize that 4D MRI is non-inferior to 2D MRI in patients with&#xD;
      corrected tetralogy of Fallot, for the evaluation of conventional cardiac evaluation&#xD;
      parameters: ventricular volume, ventricular systolic function, and regurgitation of the&#xD;
      pulmonary pathway.&#xD;
&#xD;
      The investigators hypothesize that 4D MRI is superior to 2D MRI in patients with corrected&#xD;
      tetralogy of Fallot, as ti allows to identifying new predictors of ventricular dysfunction&#xD;
      such as intravenous extracardiac turbulent / laminar flow character, preferential&#xD;
      orientation, flow distribution and trans-tricuspid diastolic flow.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date type="Actual">October 12, 2017</start_date>
  <completion_date type="Anticipated">April 11, 2020</completion_date>
  <primary_completion_date type="Actual">October 11, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Comparison of the pulmonary artery regurgitation using 2D MRI and 4D Flow MRI.</measure>
    <time_frame>20 min</time_frame>
    <description>Assessment of the pulmonary artery regurgitation using 2D MRI and 4D Flow MRI : regurgitation volume (ml) and regurgitation fraction (%).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Compare the evaluation of right ventricle volumes using 2D MRI and 4D Flow MRI.</measure>
    <time_frame>20 min</time_frame>
    <description>Assessment of the end-diastolic and end-systolic right ventricle volumes using 2D MRI and 4D Flow MRI (ml).</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Congenital Heart Disease</condition>
  <arm_group>
    <arm_group_label>4D magnetic resonance imaging</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>MRI, 4D imaging, acquisition and analysis of 4D cardiac MRI images-A single, faster acquisition (8 to 15 minutes).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2D magnetic resonance imaging</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>MRI, 2D imaging, acquisition and analysis of 2D cardiac MRI</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>magnetic resonance imaging</intervention_name>
    <description>Acquisition 4D Flow magnetic resonance Imaging-8 minutes</description>
    <arm_group_label>2D magnetic resonance imaging</arm_group_label>
    <arm_group_label>4D magnetic resonance imaging</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  - children from the age of 10 and above without any upper age limit;&#xD;
&#xD;
          -  giving their informed consent for the study;&#xD;
&#xD;
          -  with a corrected tetralogy of Fallot;&#xD;
&#xD;
          -  sent for a follow-up imaging examination with endomyocardial fibrosis screening;&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  - pregnant woman;&#xD;
&#xD;
          -  children &lt;10 years old;&#xD;
&#xD;
          -  All contraindications inherent to MRI: (claustrophobia, ferromagnetic intracorporeal&#xD;
             foreign bodies)&#xD;
&#xD;
          -  Contraindication to contrast media injection (Gadolinium)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>10 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Marc Antoine ISORNI, Doctor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hôpital Marie Lannelongue</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Olaf Mercier, Professor</last_name>
    <phone>+33140948695</phone>
    <email>o.mercier@hml.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hôpital Marie Lannelongue</name>
      <address>
        <city>Le Plessis-Robinson</city>
        <zip>92350</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marc antoine ISORNI</last_name>
      <phone>+33140948554</phone>
      <email>ma-isorni@hml.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>June 2019</verification_date>
  <study_first_submitted>May 4, 2018</study_first_submitted>
  <study_first_submitted_qc>May 30, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">June 1, 2018</study_first_posted>
  <last_update_submitted>January 21, 2020</last_update_submitted>
  <last_update_submitted_qc>January 21, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 23, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Congenital heart disease</keyword>
  <keyword>Tetralogy of Fallot</keyword>
  <keyword>Imaging by 4D Flow,</keyword>
  <keyword>Magnetic resonance imaging</keyword>
  <keyword>Prevention of ventricular dysfunction</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Diseases</mesh_term>
    <mesh_term>Heart Defects, Congenital</mesh_term>
    <mesh_term>Tetralogy of Fallot</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

